You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 160 No. 15, August 14, 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (49)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Thrombolysis
 •Venous Thromboembolism
 •Evidence-Based Medicine
 •Randomized Controlled Trial
 •Alert me on articles by topic

Low-Molecular-Weight and Unfractionated Heparin for Prevention of Venous Thromboembolism in Neurosurgery

A Meta-analysis

Alfonso Iorio, MD; Giancarlo Agnelli, MD

Arch Intern Med. 2000;160:2327-2332.

Background  Venous thromboembolism is a common, life-threatening complication in neurosurgery, but prophylaxis with anticoagulant agents has not gained wide acceptance because of concern about intracranial bleeding. We performed a meta-analysis of controlled randomized trials on the efficacy and safety of heparin in the prophylaxis of venous thromboembolism in neurosurgery.

Objective  To review the clinical benefit of prophylaxis of venous thromboembolism with heparin in the controversial setting of neurosurgery.

Methods  Relevant trials evaluating heparin for prophylaxis of venous thromboembolism in neurosurgery were identified by a MEDLINE search, scan of meeting abstracts, and scrutiny of the references of original articles and reviews. Four controlled randomized studies, 3 of which involved low-molecular-weight heparin, were included in the analysis, and 4 uncontrolled studies are commented on in the article. The outcome measure (observed minus expected number of events) and its variance were calculated for each single trial and then summed. Two-tailed P values and 95% confidence intervals (CIs) were calculated. Efficacy was assessed per protocol and safety by intention-to-treat analysis. The homogeneity of the studies was tested with the {chi}2 statistic. The results were also expressed as number needed for 1 extra event.

Results  A total of 187 thromboembolic events were recorded in 827 patients (22.6%). Heparin prophylaxis resulted in a 45% relative risk reduction of venous thromboembolic events (odds ratio [OR], 0.48; 95% CI, 0.35-0.66; P<.001). Nineteen major bleedings were recorded in 1022 patients. None were fatal. Heparin treatment resulted in a 71% relative risk increase of major bleeding (OR, 1.72; 95% CI, 0.69-4.27; P = .24). The number needed to treat was 7.7 for venous thromboembolism and 16 for proximal deep vein thrombosis. The number needed to harm was 102 (115 for low-molecular-weight heparin).

Conclusions  Low-molecular-weight and unfractionated heparin have been shown to be effective for prophylaxis of venous thromboembolism in elective neurosurgery without excessive bleeding risk.


From Azienda Ospedaliera Santa Maria Nuova, Reggio Emilia, and Sezione di Medicina Interna e Cardiovascolare, Dipartimento di Medicina Interna, Università di Perugia, Perugia, Italy.


RELATED ARTICLE

Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 2000;160(15):2404.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prevention of Venous Thromboembolism in Neurosurgery: A Metaanalysis
Collen et al.
Chest 2008;134:237-249.
ABSTRACT | FULL TEXT  

Prevention of Venous Thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Geerts et al.
Chest 2008;133:381S-453S.
ABSTRACT | FULL TEXT  

Traumatic brain injury: intensive care management
Helmy et al.
Br J Anaesth 2007;99:32-42.
ABSTRACT | FULL TEXT  

Venous thromboembolism and survival in patients with high-grade glioma
Simanek et al.
Neuro Oncol 2007;9:89-95.
ABSTRACT | FULL TEXT  

Prevention of postoperative venous thromboembolism. Risk assessment and methods of prophylaxis: [La prevention de la thromboembolie veineuse postoperatoire. Evaluation du risque et methodes de prophylaxie]
Motte et al.
Canadian J. Anesthesia 2006;53:S68-S79.
ABSTRACT | FULL TEXT  

Management of Venous Thromboembolism in Patients With Primary and Metastatic Brain Tumors
Gerber et al.
JCO 2006;24:1310-1318.
ABSTRACT | FULL TEXT  

Prevention of venous thrombosis in patients with acute intracerebral hemorrhage
Lacut et al.
Neurology 2005;65:865-869.
ABSTRACT | FULL TEXT  

Prevention of Venous Thromboembolism in Surgical Patients
Agnelli
Circulation 2004;110:IV-4-IV-12.
ABSTRACT | FULL TEXT  

Prevention of Venous Thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Geerts et al.
Chest 2004;126:338S-400S.
ABSTRACT | FULL TEXT  

Low Rate of Venous Thromboembolism After Craniotomy for Brain Tumor Using Multimodality Prophylaxis
Goldhaber et al.
Chest 2002;122:1933-1937.
ABSTRACT | FULL TEXT  

Additional articles abstracted in ACP Journal Club
Evid. Based Med. 2001;6:35-35.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.